| Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells Y Rong, W Wu, X Ni, T Kuang, D Jin, D Wang, W Lou Tumor Biology 34 (3), 1523-1530, 2013 | 206 | 2013 |
| Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer Y Fang, W Zhou, Y Rong, T Kuang, X Xu, W Wu, D Wang, W Lou Experimental cell research 383 (1), 111543, 2019 | 177 | 2019 |
| Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion H Li, MS Zeng, KR Zhou, WH Lou Journal of computer assisted tomography 29 (2), 170-175, 2005 | 152 | 2005 |
| Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study J Xu, L Shen, C Bai, W Wang, J Li, X Yu, Z Li, E Li, X Yuan, Y Chi, Y Yin, ... The Lancet Oncology 21 (11), 1489-1499, 2020 | 139 | 2020 |
| A phase I pilot trial of MUC1-peptide-pulsed dendritic cells in the treatment of advanced pancreatic cancer Y Rong, X Qin, D Jin, W Lou, L Wu, D Wang, W Wu, X Ni, Z Mao, T Kuang, ... Clinical and experimental medicine 12, 173-180, 2012 | 120 | 2012 |
| KRAS/NF-κB/YY1/miR-489 signaling axis controls pancreatic cancer metastasis P Yuan, XH He, YF Rong, J Cao, Y Li, YP Hu, Y Liu, D Li, W Lou, MF Liu Cancer research 77 (1), 100-111, 2017 | 105 | 2017 |
| Plasma miRNAs effectively distinguish patients with pancreatic cancer from controls: a multicenter study J Xu, Z Cao, W Liu, L You, L Zhou, C Wang, W Lou, B Sun, Y Miao, X Liu, ... Annals of surgery 263 (6), 1173-1179, 2016 | 93 | 2016 |
| A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline X Liu, W Zheng, W Wang, H Shen, L Liu, W Lou, X Wang, P Yang British journal of cancer 117 (12), 1846-1854, 2017 | 87 | 2017 |
| Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway N Pu, S Gao, H Yin, J Li, W Wu, Y Fang, L Zhang, Y Rong, X Xu, D Wang, ... Cancer letters 460, 42-53, 2019 | 77 | 2019 |
| CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer Q Chen, N Pu, H Yin, J Zhang, G Zhao, W Lou, W Wu Journal of cellular and molecular medicine 24 (15), 8674-8686, 2020 | 75 | 2020 |
| Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer X Liu, L Liu, Y Ji, C Li, T Wei, X Yang, Y Zhang, X Cai, Y Gao, W Xu, ... EBioMedicine 41, 345-356, 2019 | 72 | 2019 |
| Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2 Y Rong, D Jin, C Hou, J Hu, W Wu, X Ni, D Wang, W Lou BMC gastroenterology 10, 1-9, 2010 | 71 | 2010 |
| Low intratumoral regulatory T cells and high peritumoral CD8+ T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after … L Liu, G Zhao, W Wu, Y Rong, D Jin, D Wang, W Lou, X Qin Cancer Immunology, Immunotherapy 65, 73-82, 2016 | 70 | 2016 |
| The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine … X Han, C Zhang, M Tang, X Xu, L Liu, Y Ji, B Pan, W Lou European journal of gastroenterology & hepatology 27 (5), 527-535, 2015 | 69 | 2015 |
| iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma WS Wang, XH Liu, LX Liu, WH Lou, DY Jin, PY Yang, XL Wang Journal of proteomics 91, 453-465, 2013 | 67 | 2013 |
| Pancreatic adenocarcinoma: signs of vascular invasion determined by multi-detector row CT H Li, MS Zeng, KR Zhou, DY Jin, WH Lou The British journal of radiology 79 (947), 880-887, 2006 | 66 | 2006 |
| Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center X Han, X Xu, D Jin, D Wang, Y Ji, W Lou Pancreas 43 (4), 526-531, 2014 | 59 | 2014 |
| Effect of CCR7, CXCR4 and VEGF‑C on the lymph node metastasis of human pancreatic ductal adenocarcinoma J Guo, W Lou, Y Ji, S Zhang Oncology letters 5 (5), 1572-1578, 2013 | 59 | 2013 |
| Efficacy and safety of sunitinib in patients with well-differentiated pancreatic neuroendocrine tumours E Raymond, MH Kulke, S Qin, X Yu, M Schenker, A Cubillo, W Lou, ... Neuroendocrinology 107 (3), 237-245, 2018 | 57 | 2018 |
| Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study Z Cao, C Liu, J Xu, L You, C Wang, W Lou, B Sun, Y Miao, X Liu, X Wang, ... Oncotarget 7 (27), 41575, 2016 | 56 | 2016 |
